Surface modification engineering of two-dimensional titanium carbide for efficient synergistic multitherapy of breast cancer

Cancer is a leading cause of human mortality. Given that it is difficult for conventional therapeutic approaches to effectively eradicate tumors and inhibit their recurrence and metastasis, new therapeutic strategies for solving this problem are urgently needed. In this work, we report the developme...

Full description

Saved in:
Bibliographic Details
Published inJournal of materials chemistry. B, Materials for biology and medicine Vol. 8; no. 3; pp. 642 - 6417
Main Authors Bai, Lei, Yi, Wenhui, Sun, Taiyang, Tian, Yilong, Zhang, Ping, Si, Jinhai, Hou, Xun, Hou, Jin
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 05.08.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cancer is a leading cause of human mortality. Given that it is difficult for conventional therapeutic approaches to effectively eradicate tumors and inhibit their recurrence and metastasis, new therapeutic strategies for solving this problem are urgently needed. In this work, we report the development of a two-dimensional titanium carbide nanocomposite drug delivery system. The system can be used for the synergistic treatment of tumors through photothermal/photodynamic/chemotherapy and can also inhibit tumor recurrence and metastasis by activating the immune system. A surface modification engineering strategy has been elaborately designed to realize the multifunctionalization of an MXene, Ti 3 C 2 . In this strategy, the nanocomposite drug delivery system (Ti 3 C 2 @Met@CP) was established via layer by layer adsorption of metformin (Met) and compound polysaccharide (CP) on the surface of Ti 3 C 2 nanosheets. Among these materials, the synthesized (AlOH) 4 − -functionalized Ti 3 C 2 nanosheets possess strong near-infrared absorption (extinction coefficient of 36.2 L g −1 cm −1 ), high photothermal conversion efficiency (∼59.6%) and effective singlet oxygen generation ( 1 O 2 ). Compound polysaccharide (CP) is a new immunomodulator formed by mixing lentinan, pachymaran and tremella polysaccharides in optimal proportions. Especially, the decoration of CP onto the Ti 3 C 2 nanosheets endows Ti 3 C 2 with a well-defined shell, improves its tumor site aggregation and biocompatibility, and activates the host's immune functions. The synergistic eradication and inhibition of tumor recurrence and metastasis have been systematically evaluated by in vivo and in vitro experiments. A nanocomposite drug delivery system (Ti 3 C 2 @Met@CP) can be used for the synergistic treatment of tumors through photothermal/photodynamic/chemotherapy and can also inhibit tumor recurrence and metastasis by activating the immune system.
AbstractList Cancer is a leading cause of human mortality. Given that it is difficult for conventional therapeutic approaches to effectively eradicate tumors and inhibit their recurrence and metastasis, new therapeutic strategies for solving this problem are urgently needed. In this work, we report the development of a two-dimensional titanium carbide nanocomposite drug delivery system. The system can be used for the synergistic treatment of tumors through photothermal/photodynamic/chemotherapy and can also inhibit tumor recurrence and metastasis by activating the immune system. A surface modification engineering strategy has been elaborately designed to realize the multifunctionalization of an MXene, Ti 3 C 2 . In this strategy, the nanocomposite drug delivery system (Ti 3 C 2 @Met@CP) was established via layer by layer adsorption of metformin (Met) and compound polysaccharide (CP) on the surface of Ti 3 C 2 nanosheets. Among these materials, the synthesized (AlOH) 4 − -functionalized Ti 3 C 2 nanosheets possess strong near-infrared absorption (extinction coefficient of 36.2 L g −1 cm −1 ), high photothermal conversion efficiency (∼59.6%) and effective singlet oxygen generation ( 1 O 2 ). Compound polysaccharide (CP) is a new immunomodulator formed by mixing lentinan, pachymaran and tremella polysaccharides in optimal proportions. Especially, the decoration of CP onto the Ti 3 C 2 nanosheets endows Ti 3 C 2 with a well-defined shell, improves its tumor site aggregation and biocompatibility, and activates the host's immune functions. The synergistic eradication and inhibition of tumor recurrence and metastasis have been systematically evaluated by in vivo and in vitro experiments.
Cancer is a leading cause of human mortality. Given that it is difficult for conventional therapeutic approaches to effectively eradicate tumors and inhibit their recurrence and metastasis, new therapeutic strategies for solving this problem are urgently needed. In this work, we report the development of a two-dimensional titanium carbide nanocomposite drug delivery system. The system can be used for the synergistic treatment of tumors through photothermal/photodynamic/chemotherapy and can also inhibit tumor recurrence and metastasis by activating the immune system. A surface modification engineering strategy has been elaborately designed to realize the multifunctionalization of an MXene, Ti3C2. In this strategy, the nanocomposite drug delivery system (Ti3C2@Met@CP) was established via layer by layer adsorption of metformin (Met) and compound polysaccharide (CP) on the surface of Ti3C2 nanosheets. Among these materials, the synthesized (AlOH)4--functionalized Ti3C2 nanosheets possess strong near-infrared absorption (extinction coefficient of 36.2 L g-1 cm-1), high photothermal conversion efficiency (∼59.6%) and effective singlet oxygen generation (1O2). Compound polysaccharide (CP) is a new immunomodulator formed by mixing lentinan, pachymaran and tremella polysaccharides in optimal proportions. Especially, the decoration of CP onto the Ti3C2 nanosheets endows Ti3C2 with a well-defined shell, improves its tumor site aggregation and biocompatibility, and activates the host's immune functions. The synergistic eradication and inhibition of tumor recurrence and metastasis have been systematically evaluated by in vivo and in vitro experiments.
Cancer is a leading cause of human mortality. Given that it is difficult for conventional therapeutic approaches to effectively eradicate tumors and inhibit their recurrence and metastasis, new therapeutic strategies for solving this problem are urgently needed. In this work, we report the development of a two-dimensional titanium carbide nanocomposite drug delivery system. The system can be used for the synergistic treatment of tumors through photothermal/photodynamic/chemotherapy and can also inhibit tumor recurrence and metastasis by activating the immune system. A surface modification engineering strategy has been elaborately designed to realize the multifunctionalization of an MXene, Ti3C2. In this strategy, the nanocomposite drug delivery system (Ti3C2@Met@CP) was established via layer by layer adsorption of metformin (Met) and compound polysaccharide (CP) on the surface of Ti3C2 nanosheets. Among these materials, the synthesized (AlOH)4−-functionalized Ti3C2 nanosheets possess strong near-infrared absorption (extinction coefficient of 36.2 L g−1 cm−1), high photothermal conversion efficiency (∼59.6%) and effective singlet oxygen generation (1O2). Compound polysaccharide (CP) is a new immunomodulator formed by mixing lentinan, pachymaran and tremella polysaccharides in optimal proportions. Especially, the decoration of CP onto the Ti3C2 nanosheets endows Ti3C2 with a well-defined shell, improves its tumor site aggregation and biocompatibility, and activates the host's immune functions. The synergistic eradication and inhibition of tumor recurrence and metastasis have been systematically evaluated by in vivo and in vitro experiments.
Cancer is a leading cause of human mortality. Given that it is difficult for conventional therapeutic approaches to effectively eradicate tumors and inhibit their recurrence and metastasis, new therapeutic strategies for solving this problem are urgently needed. In this work, we report the development of a two-dimensional titanium carbide nanocomposite drug delivery system. The system can be used for the synergistic treatment of tumors through photothermal/photodynamic/chemotherapy and can also inhibit tumor recurrence and metastasis by activating the immune system. A surface modification engineering strategy has been elaborately designed to realize the multifunctionalization of an MXene, Ti3C2. In this strategy, the nanocomposite drug delivery system (Ti3C2@Met@CP) was established via layer by layer adsorption of metformin (Met) and compound polysaccharide (CP) on the surface of Ti3C2 nanosheets. Among these materials, the synthesized (AlOH)4--functionalized Ti3C2 nanosheets possess strong near-infrared absorption (extinction coefficient of 36.2 L g-1 cm-1), high photothermal conversion efficiency (∼59.6%) and effective singlet oxygen generation (1O2). Compound polysaccharide (CP) is a new immunomodulator formed by mixing lentinan, pachymaran and tremella polysaccharides in optimal proportions. Especially, the decoration of CP onto the Ti3C2 nanosheets endows Ti3C2 with a well-defined shell, improves its tumor site aggregation and biocompatibility, and activates the host's immune functions. The synergistic eradication and inhibition of tumor recurrence and metastasis have been systematically evaluated by in vivo and in vitro experiments.Cancer is a leading cause of human mortality. Given that it is difficult for conventional therapeutic approaches to effectively eradicate tumors and inhibit their recurrence and metastasis, new therapeutic strategies for solving this problem are urgently needed. In this work, we report the development of a two-dimensional titanium carbide nanocomposite drug delivery system. The system can be used for the synergistic treatment of tumors through photothermal/photodynamic/chemotherapy and can also inhibit tumor recurrence and metastasis by activating the immune system. A surface modification engineering strategy has been elaborately designed to realize the multifunctionalization of an MXene, Ti3C2. In this strategy, the nanocomposite drug delivery system (Ti3C2@Met@CP) was established via layer by layer adsorption of metformin (Met) and compound polysaccharide (CP) on the surface of Ti3C2 nanosheets. Among these materials, the synthesized (AlOH)4--functionalized Ti3C2 nanosheets possess strong near-infrared absorption (extinction coefficient of 36.2 L g-1 cm-1), high photothermal conversion efficiency (∼59.6%) and effective singlet oxygen generation (1O2). Compound polysaccharide (CP) is a new immunomodulator formed by mixing lentinan, pachymaran and tremella polysaccharides in optimal proportions. Especially, the decoration of CP onto the Ti3C2 nanosheets endows Ti3C2 with a well-defined shell, improves its tumor site aggregation and biocompatibility, and activates the host's immune functions. The synergistic eradication and inhibition of tumor recurrence and metastasis have been systematically evaluated by in vivo and in vitro experiments.
Cancer is a leading cause of human mortality. Given that it is difficult for conventional therapeutic approaches to effectively eradicate tumors and inhibit their recurrence and metastasis, new therapeutic strategies for solving this problem are urgently needed. In this work, we report the development of a two-dimensional titanium carbide nanocomposite drug delivery system. The system can be used for the synergistic treatment of tumors through photothermal/photodynamic/chemotherapy and can also inhibit tumor recurrence and metastasis by activating the immune system. A surface modification engineering strategy has been elaborately designed to realize the multifunctionalization of an MXene, Ti 3 C 2 . In this strategy, the nanocomposite drug delivery system (Ti 3 C 2 @Met@CP) was established via layer by layer adsorption of metformin (Met) and compound polysaccharide (CP) on the surface of Ti 3 C 2 nanosheets. Among these materials, the synthesized (AlOH) 4 − -functionalized Ti 3 C 2 nanosheets possess strong near-infrared absorption (extinction coefficient of 36.2 L g −1 cm −1 ), high photothermal conversion efficiency (∼59.6%) and effective singlet oxygen generation ( 1 O 2 ). Compound polysaccharide (CP) is a new immunomodulator formed by mixing lentinan, pachymaran and tremella polysaccharides in optimal proportions. Especially, the decoration of CP onto the Ti 3 C 2 nanosheets endows Ti 3 C 2 with a well-defined shell, improves its tumor site aggregation and biocompatibility, and activates the host's immune functions. The synergistic eradication and inhibition of tumor recurrence and metastasis have been systematically evaluated by in vivo and in vitro experiments. A nanocomposite drug delivery system (Ti 3 C 2 @Met@CP) can be used for the synergistic treatment of tumors through photothermal/photodynamic/chemotherapy and can also inhibit tumor recurrence and metastasis by activating the immune system.
Cancer is a leading cause of human mortality. Given that it is difficult for conventional therapeutic approaches to effectively eradicate tumors and inhibit their recurrence and metastasis, new therapeutic strategies for solving this problem are urgently needed. In this work, we report the development of a two-dimensional titanium carbide nanocomposite drug delivery system. The system can be used for the synergistic treatment of tumors through photothermal/photodynamic/chemotherapy and can also inhibit tumor recurrence and metastasis by activating the immune system. A surface modification engineering strategy has been elaborately designed to realize the multifunctionalization of an MXene, Ti₃C₂. In this strategy, the nanocomposite drug delivery system (Ti₃C₂@Met@CP) was established via layer by layer adsorption of metformin (Met) and compound polysaccharide (CP) on the surface of Ti₃C₂ nanosheets. Among these materials, the synthesized (AlOH)₄⁻-functionalized Ti₃C₂ nanosheets possess strong near-infrared absorption (extinction coefficient of 36.2 L g⁻¹ cm⁻¹), high photothermal conversion efficiency (∼59.6%) and effective singlet oxygen generation (¹O₂). Compound polysaccharide (CP) is a new immunomodulator formed by mixing lentinan, pachymaran and tremella polysaccharides in optimal proportions. Especially, the decoration of CP onto the Ti₃C₂ nanosheets endows Ti₃C₂ with a well-defined shell, improves its tumor site aggregation and biocompatibility, and activates the host's immune functions. The synergistic eradication and inhibition of tumor recurrence and metastasis have been systematically evaluated by in vivo and in vitro experiments.
Author Bai, Lei
Hou, Xun
Tian, Yilong
Si, Jinhai
Hou, Jin
Sun, Taiyang
Yi, Wenhui
Zhang, Ping
AuthorAffiliation Department of Pharmacology
Key Laboratory for Information Photonic Technology of Shaanxi Province & Key Laboratory for Physical Electronics and Devices of the Ministry of Education, School of Electronic Science and Engineering
Faculty of Electronic and Information Engineering
Xi'an Jiaotong University
School of Basic Medical Sciences
Xi'an Medical University
Northwest A&F University
College of science
AuthorAffiliation_xml – name: Key Laboratory for Information Photonic Technology of Shaanxi Province & Key Laboratory for Physical Electronics and Devices of the Ministry of Education, School of Electronic Science and Engineering
– name: Department of Pharmacology
– name: Northwest A&F University
– name: College of science
– name: Xi'an Jiaotong University
– name: Faculty of Electronic and Information Engineering
– name: School of Basic Medical Sciences
– name: Xi'an Medical University
Author_xml – sequence: 1
  givenname: Lei
  surname: Bai
  fullname: Bai, Lei
– sequence: 2
  givenname: Wenhui
  surname: Yi
  fullname: Yi, Wenhui
– sequence: 3
  givenname: Taiyang
  surname: Sun
  fullname: Sun, Taiyang
– sequence: 4
  givenname: Yilong
  surname: Tian
  fullname: Tian, Yilong
– sequence: 5
  givenname: Ping
  surname: Zhang
  fullname: Zhang, Ping
– sequence: 6
  givenname: Jinhai
  surname: Si
  fullname: Si, Jinhai
– sequence: 7
  givenname: Xun
  surname: Hou
  fullname: Hou, Xun
– sequence: 8
  givenname: Jin
  surname: Hou
  fullname: Hou, Jin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32573629$$D View this record in MEDLINE/PubMed
BookMark eNqF0k1rFTEUBuAgFVtrN-6ViBsRRvM1X0ut2hYKLqzgbjiTnFxTZpJrkkEu-OPN7a1XKFKzmcB53rPIO4_JgQ8eCXnK2RvOZP_WsDwyzjq1ekCOBKtZ1da8O9jf2bdDcpLSNSun400n1SNyKEXdykb0R-TXlyVa0EjnYJx1GrILnqJfOY8YnV_RYGn-GSrjZvSpDGGi2WXwbpmphjg6g9SGSNGWuEOfadp4jCuXstN0Xqaiv2OE9Wa7aowIKZeg1xifkIcWpoQnt99j8vXTx6vT8-ry89nF6bvLStdS5Mpy3gGrWwNK27a2SjGBltcKpOw0b3kLXEkQisEIBnpZG6tHMYK0aHtt5TF5tdu7juHHgikPs0sapwk8hiUNou-aWjWc8_9TxRvRKClEoS_v0OuwxPI-WyWZ5LJhsqjnt2oZZzTDOroZ4mb4U0EBr3dAx5BSRLsnnA3biocP7Or9TcVnBbM7WJcutp3lCG76d-TZLhKT3q_--9eU-Yv75sPaWPkbvf-_Ag
CitedBy_id crossref_primary_10_1016_j_matdes_2023_111656
crossref_primary_10_1515_nanoph_2021_0171
crossref_primary_10_1021_acsami_2c08678
crossref_primary_10_1016_j_enconman_2022_116432
crossref_primary_10_1002_smll_202103993
crossref_primary_10_1002_smll_202201989
crossref_primary_10_1039_D1TB01938D
crossref_primary_10_1088_2053_1583_acc413
crossref_primary_10_1021_acsami_4c07894
crossref_primary_10_1016_j_addr_2022_114422
crossref_primary_10_1016_j_matchemphys_2024_130088
crossref_primary_10_1186_s12951_023_01809_2
crossref_primary_10_1016_j_jiec_2025_02_020
crossref_primary_10_1016_j_diamond_2023_109883
crossref_primary_10_1016_j_envres_2023_115337
crossref_primary_10_1186_s12951_022_01331_x
crossref_primary_10_1186_s12951_025_03288_z
crossref_primary_10_3390_nano11123412
crossref_primary_10_1016_j_rser_2024_114952
crossref_primary_10_1002_anbr_202200123
crossref_primary_10_1016_j_addr_2022_114178
crossref_primary_10_1142_S179329202430010X
crossref_primary_10_1016_j_jiec_2024_09_057
crossref_primary_10_1016_j_mtsust_2023_100619
crossref_primary_10_1021_acsnano_3c04037
crossref_primary_10_1002_ps_6538
crossref_primary_10_1016_j_cej_2025_160430
crossref_primary_10_1186_s12938_021_00873_9
crossref_primary_10_3390_pharmaceutics14020322
crossref_primary_10_1039_D2TA01140A
crossref_primary_10_3390_pharmaceutics13111803
crossref_primary_10_1016_j_mtchem_2022_101205
crossref_primary_10_1515_nanoph_2021_0390
crossref_primary_10_1039_D3NR02527F
crossref_primary_10_3390_bios12070454
crossref_primary_10_1007_s13346_024_01572_3
crossref_primary_10_1016_j_cclet_2023_108180
crossref_primary_10_1039_D2EN00527A
crossref_primary_10_1039_D4TB02834A
crossref_primary_10_1016_j_diamond_2025_112025
crossref_primary_10_1080_21622515_2025_2475260
crossref_primary_10_1515_nanoph_2022_0514
crossref_primary_10_1016_j_ijbiomac_2024_130960
crossref_primary_10_1016_j_mtcomm_2024_109929
crossref_primary_10_1016_j_ccr_2020_213662
crossref_primary_10_3390_ijms23105816
crossref_primary_10_1039_D1QM01277K
crossref_primary_10_1088_1402_4896_acfcf0
crossref_primary_10_1021_acsami_0c18474
crossref_primary_10_1016_j_ijbiomac_2022_07_070
crossref_primary_10_1016_j_jhazmat_2023_131531
crossref_primary_10_1002_adhm_202302604
crossref_primary_10_1021_acsami_4c08129
crossref_primary_10_1039_D4TB02478H
crossref_primary_10_1002_adfm_202203430
crossref_primary_10_1016_j_cej_2021_131925
crossref_primary_10_1016_j_mtsust_2024_100896
crossref_primary_10_1002_smll_202102557
crossref_primary_10_1016_j_colsurfb_2024_114074
crossref_primary_10_1016_j_envres_2021_111592
crossref_primary_10_1016_j_intimp_2025_114411
crossref_primary_10_1016_j_molliq_2023_123246
crossref_primary_10_1016_j_ijbiomac_2024_133583
crossref_primary_10_1039_D1BM01957K
crossref_primary_10_1016_j_cej_2024_156730
crossref_primary_10_1016_j_progsolidstchem_2022_100370
crossref_primary_10_1039_D1CS01148K
crossref_primary_10_1016_j_cej_2022_140167
crossref_primary_10_15541_jim20210299
crossref_primary_10_1016_j_actbio_2022_02_019
crossref_primary_10_1016_j_jddst_2023_104404
crossref_primary_10_1016_j_jddst_2023_104569
crossref_primary_10_1002_advs_202003041
crossref_primary_10_1039_D1BM00526J
Cites_doi 10.1155/2017/9459156
10.1002/smll.201402092
10.1016/j.biomaterials.2011.11.064
10.1021/acsami.6b07326
10.1039/C8TA09600G
10.1002/adma.201102306
10.1002/anie.201506154
10.1002/smll.201603446
10.1016/j.ijbiomac.2012.09.025
10.1039/C8TB02491J
10.1021/acsnano.9b04436
10.1002/adfm.201704135
10.1021/acsami.7b13421
10.1039/C8BM00381E
10.1016/j.ijbiomac.2012.01.002
10.1016/j.ijbiomac.2019.06.183
10.1002/adhm.201701394
10.1021/acsnano.8b05982
10.1007/s12013-014-0242-8
10.1039/C8CS00324F
10.1021/acsnano.8b02235
10.1002/adfm.201202502
10.1158/0008-5472.CAN-06-1500
10.1021/ja2010175
10.1002/adma.201304138
10.1021/bc0498166
10.1021/acsnano.6b00181
10.1021/acsami.6b04591
10.1016/j.clay.2017.02.015
10.1021/acs.jpclett.5b01895
10.1016/j.carbpol.2012.06.042
10.4161/cc.8.6.7933
10.1039/C5NR08166A
10.1016/j.suronc.2014.11.002
10.1016/S0031-9384(96)00451-9
10.1002/adfm.201605926
10.2337/diabetes.49.12.2063
10.1002/adma.201305256
10.1002/adma.201104964
10.1021/acs.nanolett.6b04339
10.1021/acsnano.6b08415
10.1021/nn501647j
10.1016/j.procbio.2013.06.012
10.1038/nrc1070
10.1021/acs.chemrev.7b00258
10.1002/advs.201800510
10.2147/IJN.S165232
10.1021/jacs.5b06025
10.1021/acsnano.5b05825
10.3322/caac.20114
10.1002/adma.201506306
10.1016/j.jconrel.2015.11.016
10.1038/nnano.2010.235
10.1016/j.imlet.2006.01.009
10.1158/0008-5472.CAN-05-4193
10.1038/natrevmats.2016.98
10.3322/caac.21395
10.1016/j.cclet.2018.07.007
10.1016/j.biomaterials.2010.08.096
10.1002/adma.201202211
10.1002/anie.200602471
10.1002/adma.201902333
10.1039/C7BM01206C
10.1002/asia.201402715
10.1002/adma.201504657
10.1021/acs.chemmater.7b02441
10.1002/anie.201209229
10.1002/adma.201703284
10.1002/anie.201410174
10.1039/C8NR05301D
ContentType Journal Article
Copyright Copyright Royal Society of Chemistry 2020
Copyright_xml – notice: Copyright Royal Society of Chemistry 2020
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QF
7QO
7QQ
7SC
7SE
7SP
7SR
7TA
7TB
7U5
8BQ
8FD
F28
FR3
H8D
H8G
JG9
JQ2
K9.
KR7
L7M
L~C
L~D
P64
7X8
7S9
L.6
DOI 10.1039/d0tb01084g
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Aluminium Industry Abstracts
Biotechnology Research Abstracts
Ceramic Abstracts
Computer and Information Systems Abstracts
Corrosion Abstracts
Electronics & Communications Abstracts
Engineered Materials Abstracts
Materials Business File
Mechanical & Transportation Engineering Abstracts
Solid State and Superconductivity Abstracts
METADEX
Technology Research Database
ANTE: Abstracts in New Technology & Engineering
Engineering Research Database
Aerospace Database
Copper Technical Reference Library
Materials Research Database
ProQuest Computer Science Collection
ProQuest Health & Medical Complete (Alumni)
Civil Engineering Abstracts
Advanced Technologies Database with Aerospace
Computer and Information Systems Abstracts – Academic
Computer and Information Systems Abstracts Professional
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Materials Research Database
Civil Engineering Abstracts
Aluminium Industry Abstracts
Technology Research Database
Computer and Information Systems Abstracts – Academic
Mechanical & Transportation Engineering Abstracts
Electronics & Communications Abstracts
ProQuest Computer Science Collection
Computer and Information Systems Abstracts
ProQuest Health & Medical Complete (Alumni)
Ceramic Abstracts
Materials Business File
METADEX
Biotechnology and BioEngineering Abstracts
Computer and Information Systems Abstracts Professional
Aerospace Database
Copper Technical Reference Library
Engineered Materials Abstracts
Biotechnology Research Abstracts
Solid State and Superconductivity Abstracts
Engineering Research Database
Corrosion Abstracts
Advanced Technologies Database with Aerospace
ANTE: Abstracts in New Technology & Engineering
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList CrossRef
MEDLINE
Materials Research Database
MEDLINE - Academic

AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 2050-7518
EndPage 6417
ExternalDocumentID 32573629
10_1039_D0TB01084G
d0tb01084g
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0-7
0R
4.4
53G
705
AAEMU
AAGNR
AAIWI
AANOJ
ABDVN
ABGFH
ABRYZ
ACGFS
ACIWK
ACLDK
ACPRK
ADMRA
ADSRN
AENEX
AFRAH
AFVBQ
AGSTE
AGSWI
ALMA_UNASSIGNED_HOLDINGS
ASKNT
AUDPV
BLAPV
BSQNT
C6K
CKLOX
D0L
EBS
ECGLT
EE0
EF-
GNO
HZ
H~N
J3I
JG
O-G
O9-
R7C
RCNCU
RIG
RNS
RPMJG
RRC
RSCEA
SKA
SKF
SLH
UCJ
0R~
AAJAE
AAWGC
AAXHV
AAYXX
ABASK
ABEMK
ABJNI
ABPDG
ABXOH
AEFDR
AENGV
AESAV
AETIL
AFLYV
AFOGI
AFRDS
AFRZK
AGEGJ
AGRSR
AHGCF
AKMSF
ALUYA
ANUXI
APEMP
CITATION
GGIMP
H13
HZ~
RAOCF
CGR
CUY
CVF
ECM
EIF
NPM
7QF
7QO
7QQ
7SC
7SE
7SP
7SR
7TA
7TB
7U5
8BQ
8FD
F28
FR3
H8D
H8G
JG9
JQ2
K9.
KR7
L7M
L~C
L~D
P64
7X8
7S9
L.6
ID FETCH-LOGICAL-c532t-f118a057da4cf75f4402ef154a338c1717a143a240abada935dfcb2ba3fef9cf3
ISSN 2050-750X
2050-7518
IngestDate Fri Jul 11 12:34:16 EDT 2025
Fri Jul 11 16:19:23 EDT 2025
Mon Jun 30 08:06:31 EDT 2025
Mon Jul 21 05:59:25 EDT 2025
Tue Jul 01 01:00:27 EDT 2025
Thu Apr 24 23:04:36 EDT 2025
Sat Jan 08 03:53:01 EST 2022
Wed Nov 11 00:27:41 EST 2020
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c532t-f118a057da4cf75f4402ef154a338c1717a143a240abada935dfcb2ba3fef9cf3
Notes 10.1039/d0tb01084g
Electronic supplementary information (ESI) available. See DOI
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4044-0444
0000-0001-9110-5737
PMID 32573629
PQID 2430313603
PQPubID 2047522
PageCount 16
ParticipantIDs crossref_primary_10_1039_D0TB01084G
rsc_primary_d0tb01084g
crossref_citationtrail_10_1039_D0TB01084G
proquest_miscellaneous_2416264322
pubmed_primary_32573629
proquest_journals_2430313603
proquest_miscellaneous_2986546111
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20200805
PublicationDateYYYYMMDD 2020-08-05
PublicationDate_xml – month: 8
  year: 2020
  text: 20200805
  day: 5
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Cambridge
PublicationTitle Journal of materials chemistry. B, Materials for biology and medicine
PublicationTitleAlternate J Mater Chem B
PublicationYear 2020
Publisher Royal Society of Chemistry
Publisher_xml – name: Royal Society of Chemistry
References Peng (D0TB01084G-(cit15)/*[position()=1]) 2018; 6
Guo (D0TB01084G-(cit56)/*[position()=1]) 2012; 50
Yuwen (D0TB01084G-(cit67)/*[position()=1]) 2016; 8
Hundal (D0TB01084G-(cit61)/*[position()=1]) 2000; 49
Fan (D0TB01084G-(cit6)/*[position()=1]) 2017; 117
Tian (D0TB01084G-(cit9)/*[position()=1]) 2019; 137
Kalluru (D0TB01084G-(cit10)/*[position()=1]) 2013
Naguib (D0TB01084G-(cit31)/*[position()=1]) 2011; 23
Liu (D0TB01084G-(cit70)/*[position()=1]) 2017; 27
Liu (D0TB01084G-(cit26)/*[position()=1]) 2014; 26
Wang (D0TB01084G-(cit68)/*[position()=1]) 2015; 137
Cheng (D0TB01084G-(cit17)/*[position()=1]) 2019; 13
Felsher (D0TB01084G-(cit5)/*[position()=1]) 2003; 3
Zhu (D0TB01084G-(cit73)/*[position()=1]) 2015; 10
Xu (D0TB01084G-(cit39)/*[position()=1]) 2016; 28
Yong (D0TB01084G-(cit66)/*[position()=1]) 2015; 9
Guo (D0TB01084G-(cit55)/*[position()=1]) 2012; 90
Liu (D0TB01084G-(cit13)/*[position()=1]) 2011; 32
Zeynabad (D0TB01084G-(cit72)/*[position()=1]) 2017; 141
Zeng (D0TB01084G-(cit30)/*[position()=1]) 2018; 5
Zhang (D0TB01084G-(cit38)/*[position()=1]) 2019; 30
Hao (D0TB01084G-(cit7)/*[position()=1]) 2015; 220
Chen (D0TB01084G-(cit14)/*[position()=1]) 2018; 12
Cheng (D0TB01084G-(cit16)/*[position()=1]) 2017; 27
Yin (D0TB01084G-(cit27)/*[position()=1]) 2014; 8
Zakikhani (D0TB01084G-(cit62)/*[position()=1]) 2006; 66
Bae (D0TB01084G-(cit69)/*[position()=1]) 2005; 16
Kim (D0TB01084G-(cit8)/*[position()=1]) 2006; 45
Anasori (D0TB01084G-(cit37)/*[position()=1]) 2017; 2
Yang (D0TB01084G-(cit41)/*[position()=1]) 2018; 10
Han (D0TB01084G-(cit43)/*[position()=1]) 2018; 7
Xing (D0TB01084G-(cit50)/*[position()=1]) 2016; 8
Chen (D0TB01084G-(cit18)/*[position()=1]) 2017; 13
Naguib (D0TB01084G-(cit32)/*[position()=1]) 2014; 26
Liang (D0TB01084G-(cit35)/*[position()=1]) 2015; 54
Shen (D0TB01084G-(cit57)/*[position()=1]) 2018; 6
Tang (D0TB01084G-(cit59)/*[position()=1]) 2019; 13
Zha (D0TB01084G-(cit2)/*[position()=1]) 2013; 25
Tamura (D0TB01084G-(cit51)/*[position()=1]) 1997; 61
Geng (D0TB01084G-(cit11)/*[position()=1]) 2015; 11
Lin (D0TB01084G-(cit40)/*[position()=1]) 2017; 17
Khazaei (D0TB01084G-(cit33)/*[position()=1]) 2013; 23
Liu (D0TB01084G-(cit45)/*[position()=1]) 2017; 9
Sun (D0TB01084G-(cit29)/*[position()=1]) 2015; 54
Zhang (D0TB01084G-(cit52)/*[position()=1]) 2017; 2017
Jose (D0TB01084G-(cit63)/*[position()=1]) 2015; 71
Yu (D0TB01084G-(cit44)/*[position()=1]) 2018; 6
Sun (D0TB01084G-(cit49)/*[position()=1]) 2015; 24
Siegel (D0TB01084G-(cit1)/*[position()=1]) 2017; 67
Gatenby (D0TB01084G-(cit71)/*[position()=1]) 2006; 66
Zhang (D0TB01084G-(cit12)/*[position()=1]) 2018; 13
Pang (D0TB01084G-(cit36)/*[position()=1]) 2019; 48
Gao (D0TB01084G-(cit74)/*[position()=1]) 2019; 7
Yang (D0TB01084G-(cit3)/*[position()=1]) 2012; 24
Lin (D0TB01084G-(cit65)/*[position()=1]) 2018; 30
Robinson (D0TB01084G-(cit22)/*[position()=1]) 2011; 133
Zhang (D0TB01084G-(cit47)/*[position()=1]) 2013; 52
Lei (D0TB01084G-(cit25)/*[position()=1]) 2016; 8
Chou (D0TB01084G-(cit28)/*[position()=1]) 2013; 52
Sheu (D0TB01084G-(cit48)/*[position()=1]) 2013; 48
Yang (D0TB01084G-(cit23)/*[position()=1]) 2012; 33
Alimova (D0TB01084G-(cit64)/*[position()=1]) 2009; 8
Rasool (D0TB01084G-(cit60)/*[position()=1]) 2016; 10
Ren (D0TB01084G-(cit34)/*[position()=1]) 2015; 6
Yang (D0TB01084G-(cit21)/*[position()=1]) 2012; 24
Li (D0TB01084G-(cit58)/*[position()=1]) 2017; 11
Agostinis (D0TB01084G-(cit4)/*[position()=1]) 2011; 61
Huang (D0TB01084G-(cit24)/*[position()=1]) 2011; 6
Cheng (D0TB01084G-(cit19)/*[position()=1]) 2019; 32
Dai (D0TB01084G-(cit42)/*[position()=1]) 2017; 29
Yan (D0TB01084G-(cit54)/*[position()=1]) 2010; 48
Leung (D0TB01084G-(cit46)/*[position()=1]) 2006; 105
Ma (D0TB01084G-(cit53)/*[position()=1]) 1992; 27
Kurapati (D0TB01084G-(cit20)/*[position()=1]) 2016; 28
39474772 - J Mater Chem B. 2024 Oct 30. doi: 10.1039/d4tb90175d
References_xml – issn: 2013
  issue: 52
  end-page: 12332-12336
  publication-title: Angew. Chem., Int. Ed. Engl.
  doi: Kalluru Vankayala Chiang Hwang
– volume: 2017
  start-page: 9459156
  year: 2017
  ident: D0TB01084G-(cit52)/*[position()=1]
  publication-title: J. Evidence-Based Complementary Altern. Med.
  doi: 10.1155/2017/9459156
– volume: 11
  start-page: 1603
  year: 2015
  ident: D0TB01084G-(cit11)/*[position()=1]
  publication-title: Small
  doi: 10.1002/smll.201402092
– volume: 33
  start-page: 2206
  year: 2012
  ident: D0TB01084G-(cit23)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2011.11.064
– volume: 8
  start-page: 20900
  year: 2016
  ident: D0TB01084G-(cit25)/*[position()=1]
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.6b07326
– volume: 6
  start-page: 23513
  year: 2018
  ident: D0TB01084G-(cit57)/*[position()=1]
  publication-title: J. Mater. Chem. A
  doi: 10.1039/C8TA09600G
– volume: 23
  start-page: 4248
  year: 2011
  ident: D0TB01084G-(cit31)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201102306
– volume: 54
  start-page: 11526
  year: 2015
  ident: D0TB01084G-(cit29)/*[position()=1]
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.201506154
– volume: 13
  start-page: 1603446
  issue: 10
  year: 2017
  ident: D0TB01084G-(cit18)/*[position()=1]
  publication-title: Small
  doi: 10.1002/smll.201603446
– volume: 52
  start-page: 212
  year: 2013
  ident: D0TB01084G-(cit47)/*[position()=1]
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2012.09.025
– volume: 7
  start-page: 709
  year: 2019
  ident: D0TB01084G-(cit74)/*[position()=1]
  publication-title: J. Mater. Chem. B
  doi: 10.1039/C8TB02491J
– volume: 13
  start-page: 8537
  year: 2019
  ident: D0TB01084G-(cit17)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.9b04436
– volume: 27
  start-page: 1704135
  issue: 45
  year: 2017
  ident: D0TB01084G-(cit16)/*[position()=1]
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201704135
– volume: 9
  start-page: 40077
  year: 2017
  ident: D0TB01084G-(cit45)/*[position()=1]
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.7b13421
– volume: 6
  start-page: 2144
  year: 2018
  ident: D0TB01084G-(cit44)/*[position()=1]
  publication-title: Biomater. Sci.
  doi: 10.1039/C8BM00381E
– volume: 50
  start-page: 512
  year: 2012
  ident: D0TB01084G-(cit56)/*[position()=1]
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2012.01.002
– volume: 137
  start-page: 904
  year: 2019
  ident: D0TB01084G-(cit9)/*[position()=1]
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2019.06.183
– volume: 7
  start-page: 1701394
  issue: 9
  year: 2018
  ident: D0TB01084G-(cit43)/*[position()=1]
  publication-title: Adv. Healthcare Mater.
  doi: 10.1002/adhm.201701394
– volume: 13
  start-page: 284
  year: 2019
  ident: D0TB01084G-(cit59)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.8b05982
– volume: 71
  start-page: 627
  year: 2015
  ident: D0TB01084G-(cit63)/*[position()=1]
  publication-title: Cell Biochem. Biophys.
  doi: 10.1007/s12013-014-0242-8
– volume: 48
  start-page: 72
  year: 2019
  ident: D0TB01084G-(cit36)/*[position()=1]
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/C8CS00324F
– volume: 12
  start-page: 5995
  year: 2018
  ident: D0TB01084G-(cit14)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.8b02235
– volume: 23
  start-page: 2185
  year: 2013
  ident: D0TB01084G-(cit33)/*[position()=1]
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201202502
– volume: 66
  start-page: 10269
  year: 2006
  ident: D0TB01084G-(cit62)/*[position()=1]
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-06-1500
– volume: 133
  start-page: 6825
  year: 2011
  ident: D0TB01084G-(cit22)/*[position()=1]
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja2010175
– volume: 26
  start-page: 992
  year: 2014
  ident: D0TB01084G-(cit32)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201304138
– volume: 16
  start-page: 122
  year: 2005
  ident: D0TB01084G-(cit69)/*[position()=1]
  publication-title: Bioconjugate Chem.
  doi: 10.1021/bc0498166
– volume: 10
  start-page: 3674
  year: 2016
  ident: D0TB01084G-(cit60)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.6b00181
– volume: 8
  start-page: 19276
  year: 2016
  ident: D0TB01084G-(cit50)/*[position()=1]
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.6b04591
– volume: 141
  start-page: 23
  year: 2017
  ident: D0TB01084G-(cit72)/*[position()=1]
  publication-title: Appl. Clay Sci.
  doi: 10.1016/j.clay.2017.02.015
– volume: 6
  start-page: 4026
  year: 2015
  ident: D0TB01084G-(cit34)/*[position()=1]
  publication-title: J. Phys. Chem. Lett.
  doi: 10.1021/acs.jpclett.5b01895
– volume: 27
  start-page: 1
  year: 1992
  ident: D0TB01084G-(cit53)/*[position()=1]
  publication-title: Yao Hsueh Hsueh Pao Acta Pharm. Sin.
– volume: 90
  start-page: 1055
  year: 2012
  ident: D0TB01084G-(cit55)/*[position()=1]
  publication-title: Carbohydr. Polym.
  doi: 10.1016/j.carbpol.2012.06.042
– volume: 8
  start-page: 909
  year: 2009
  ident: D0TB01084G-(cit64)/*[position()=1]
  publication-title: Cell Cycle
  doi: 10.4161/cc.8.6.7933
– volume: 8
  start-page: 2720
  year: 2016
  ident: D0TB01084G-(cit67)/*[position()=1]
  publication-title: Nanoscale
  doi: 10.1039/C5NR08166A
– volume: 24
  start-page: 28
  year: 2015
  ident: D0TB01084G-(cit49)/*[position()=1]
  publication-title: J. Surg. Oncol.
  doi: 10.1016/j.suronc.2014.11.002
– volume: 61
  start-page: 399
  year: 1997
  ident: D0TB01084G-(cit51)/*[position()=1]
  publication-title: Physiol. Behav.
  doi: 10.1016/S0031-9384(96)00451-9
– volume: 27
  start-page: 1605926
  issue: 10
  year: 2017
  ident: D0TB01084G-(cit70)/*[position()=1]
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201605926
– volume: 49
  start-page: 2063
  year: 2000
  ident: D0TB01084G-(cit61)/*[position()=1]
  publication-title: Diabetes
  doi: 10.2337/diabetes.49.12.2063
– volume: 26
  start-page: 3433
  year: 2014
  ident: D0TB01084G-(cit26)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201305256
– volume: 24
  start-page: 1868
  year: 2012
  ident: D0TB01084G-(cit21)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201104964
– volume: 17
  start-page: 384
  year: 2017
  ident: D0TB01084G-(cit40)/*[position()=1]
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.6b04339
– volume: 11
  start-page: 3752
  year: 2017
  ident: D0TB01084G-(cit58)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.6b08415
– volume: 24
  start-page: 1868
  year: 2012
  ident: D0TB01084G-(cit3)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201104964
– volume: 8
  start-page: 6922
  year: 2014
  ident: D0TB01084G-(cit27)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/nn501647j
– volume: 48
  start-page: 1402
  year: 2013
  ident: D0TB01084G-(cit48)/*[position()=1]
  publication-title: Process Biochem.
  doi: 10.1016/j.procbio.2013.06.012
– volume: 3
  start-page: 375
  year: 2003
  ident: D0TB01084G-(cit5)/*[position()=1]
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1070
– volume: 117
  start-page: 13566
  year: 2017
  ident: D0TB01084G-(cit6)/*[position()=1]
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.7b00258
– volume: 5
  start-page: 1800510
  issue: 10
  year: 2018
  ident: D0TB01084G-(cit30)/*[position()=1]
  publication-title: Adv. Sci.
  doi: 10.1002/advs.201800510
– volume: 13
  start-page: 3069
  year: 2018
  ident: D0TB01084G-(cit12)/*[position()=1]
  publication-title: Int. J. Nanomed.
  doi: 10.2147/IJN.S165232
– volume: 48
  start-page: 94
  year: 2010
  ident: D0TB01084G-(cit54)/*[position()=1]
  publication-title: Food Technol. Biotechnol.
– volume: 137
  start-page: 11376
  year: 2015
  ident: D0TB01084G-(cit68)/*[position()=1]
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.5b06025
– volume: 9
  start-page: 12451
  year: 2015
  ident: D0TB01084G-(cit66)/*[position()=1]
  publication-title: ACS Nano
  doi: 10.1021/acsnano.5b05825
– volume: 61
  start-page: 250
  year: 2011
  ident: D0TB01084G-(cit4)/*[position()=1]
  publication-title: Ca-Cancer J. Clin.
  doi: 10.3322/caac.20114
– volume: 28
  start-page: 6052
  year: 2016
  ident: D0TB01084G-(cit20)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201506306
– volume: 220
  start-page: 545
  year: 2015
  ident: D0TB01084G-(cit7)/*[position()=1]
  publication-title: J. Controlled Release
  doi: 10.1016/j.jconrel.2015.11.016
– volume: 6
  start-page: 28
  year: 2011
  ident: D0TB01084G-(cit24)/*[position()=1]
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2010.235
– volume: 105
  start-page: 101
  year: 2006
  ident: D0TB01084G-(cit46)/*[position()=1]
  publication-title: Immunol. Lett.
  doi: 10.1016/j.imlet.2006.01.009
– volume: 66
  start-page: 5216
  year: 2006
  ident: D0TB01084G-(cit71)/*[position()=1]
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-05-4193
– volume: 2
  start-page: 16098
  issue: 2
  year: 2017
  ident: D0TB01084G-(cit37)/*[position()=1]
  publication-title: Nat. Rev. Mater.
  doi: 10.1038/natrevmats.2016.98
– volume: 67
  start-page: 177
  year: 2017
  ident: D0TB01084G-(cit1)/*[position()=1]
  publication-title: Ca-Cancer J. Clin.
  doi: 10.3322/caac.21395
– volume: 30
  start-page: 502
  year: 2019
  ident: D0TB01084G-(cit38)/*[position()=1]
  publication-title: Chin. Chem. Lett.
  doi: 10.1016/j.cclet.2018.07.007
– volume: 32
  start-page: 144
  year: 2011
  ident: D0TB01084G-(cit13)/*[position()=1]
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2010.08.096
– volume: 25
  start-page: 777
  year: 2013
  ident: D0TB01084G-(cit2)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201202211
– volume: 45
  start-page: 7754
  year: 2006
  ident: D0TB01084G-(cit8)/*[position()=1]
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.200602471
– volume: 32
  start-page: 1902333
  issue: 13
  year: 2019
  ident: D0TB01084G-(cit19)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201902333
– volume: 6
  start-page: 1084
  year: 2018
  ident: D0TB01084G-(cit15)/*[position()=1]
  publication-title: Biomater. Sci.
  doi: 10.1039/C7BM01206C
– volume: 10
  start-page: 284
  year: 2015
  ident: D0TB01084G-(cit73)/*[position()=1]
  publication-title: Chem. – Asian J.
  doi: 10.1002/asia.201402715
– volume: 28
  start-page: 3333
  year: 2016
  ident: D0TB01084G-(cit39)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201504657
– volume: 29
  start-page: 8637
  year: 2017
  ident: D0TB01084G-(cit42)/*[position()=1]
  publication-title: Chem. Mater.
  doi: 10.1021/acs.chemmater.7b02441
– volume: 52
  start-page: 4160
  year: 2013
  ident: D0TB01084G-(cit28)/*[position()=1]
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.201209229
– volume: 30
  start-page: 1703284
  issue: 4
  year: 2018
  ident: D0TB01084G-(cit65)/*[position()=1]
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201703284
– volume-title: Angew. Chem., Int. Ed. Engl.
  year: 2013
  ident: D0TB01084G-(cit10)/*[position()=1]
– volume: 54
  start-page: 3907
  year: 2015
  ident: D0TB01084G-(cit35)/*[position()=1]
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.201410174
– volume: 10
  start-page: 15387
  year: 2018
  ident: D0TB01084G-(cit41)/*[position()=1]
  publication-title: Nanoscale
  doi: 10.1039/C8NR05301D
– reference: 39474772 - J Mater Chem B. 2024 Oct 30. doi: 10.1039/d4tb90175d
SSID ssj0000816834
Score 2.5090084
Snippet Cancer is a leading cause of human mortality. Given that it is difficult for conventional therapeutic approaches to effectively eradicate tumors and inhibit...
SourceID proquest
pubmed
crossref
rsc
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 642
SubjectTerms absorption
adsorption
Animals
Antineoplastic Combined Chemotherapy Protocols - chemistry
Antineoplastic Combined Chemotherapy Protocols - pharmacology
Biocompatibility
Biocompatible Materials - chemistry
Breast cancer
breast neoplasms
Breast Neoplasms - drug therapy
Breast Neoplasms - radiotherapy
Chemotherapy
Combined Modality Therapy
Drug delivery
Drug delivery systems
Drug Liberation
drug therapy
Female
Glucans - chemistry
Glucans - pharmacology
Humans
Immune system
Immunomodulation
Immunomodulators
Infrared absorption
Infrared Rays
Lentinan
Lentinan - chemistry
Lentinan - pharmacology
Metastases
Metastasis
Metformin
Metformin - chemistry
Mice, Inbred BALB C
Mice, Nude
mortality
Nanocapsules - chemistry
Nanocomposites
Nanocomposites - chemistry
nanosheets
Nanostructure
Near infrared radiation
Phototherapy
Photothermal conversion
Polysaccharides
Polysaccharides - chemistry
Saccharides
Singlet oxygen
Singlet Oxygen - chemistry
Titanium
Titanium - chemistry
Titanium carbide
Tumors
Title Surface modification engineering of two-dimensional titanium carbide for efficient synergistic multitherapy of breast cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/32573629
https://www.proquest.com/docview/2430313603
https://www.proquest.com/docview/2416264322
https://www.proquest.com/docview/2986546111
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZKJ6HtYeI2yBjICF7QlC2JnTZ53GAw0OBlnRhPkeMLRFqTqk2Ehvgv_FWOL0kDLQh4iSrbdS_ns32Oz3fOQegZz6NQm8m-VCH1qYpCP-ERN95HOOBoSpS-73j3fnR6Qd9expeDwfcea6mp8wP-dW1cyf9IFdpArjpK9h8k200KDfAa5AtPkDA8_0rG581cMViY00poxo-VpVxmGDQEgC-VL3QK_4VjlhegDhbNVOekzgvhcn6bRBKaFrC41sGAJnuzJRvaAC3jh881gb3WPDHuOL2rWi0owPaX7_O2lNzB_rGNCmp7DEO0l_xpxb9vS2SfyaLbk0zDB1l-brq288YWVmbFNXPHr6ET2xvdj8VV5VrdnUZkGXXWuS3N3hcFceBrj1B_o056eHTOHLvrjqiJ2l49DgKis6mKoM7B7Ezop_4gEOVsaoBBYNuCczxdHokdUbHtuoE2IrBDoiHaODqZvDnrrvFM3RJC28S3JD1cftomutm-_2etZ8WUAcVm3hacMYrN5BbadrLDRxZet9FAlnfQVi9P5V30zQEN94GGe0DDlcK_AA23QMMOaBjEjjug4R7QcB9oeioLNGyBdg9dvDqZvDj1XdkOn8ckqn0FNisDM0AwytU4VhSkAztBTBkhCQ_H4ZiBks5AlWQ5EywlsVCwZeSMKKlSrsgOGpZVKR8gLAOh8kiCTRyPqEokUyrkguRC5yUkY-Wh5-3fmnGX016XVrnKDLeCpNnLYHJspPHaQ0-7sTObyWXtqL1WOplb6YssokSnOB0FxENPum5YQ9q5xkpZNXpMOALjAs7HP4xJEx07COqFh-5byXdfpUWKh3YACl3zEk0e2l3fkc2E2v3tfA_R5nKF7aFhPW_kI9Cj6_yxw_IPs13Pnw
linkProvider Royal Society of Chemistry
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Surface+modification+engineering+of+two-dimensional+titanium+carbide+for+efficient+synergistic+multitherapy+of+breast+cancer&rft.jtitle=Journal+of+materials+chemistry.+B%2C+Materials+for+biology+and+medicine&rft.au=Bai%2C+Lei&rft.au=Yi%2C+Wenhui&rft.au=Sun%2C+Taiyang&rft.au=Tian%2C+Yilong&rft.date=2020-08-05&rft.eissn=2050-7518&rft.volume=8&rft.issue=30&rft.spage=6402&rft_id=info:doi/10.1039%2Fd0tb01084g&rft_id=info%3Apmid%2F32573629&rft.externalDocID=32573629
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2050-750X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2050-750X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2050-750X&client=summon